Search

The G-ROP model was proposed to improve the retinopathy of prematurity (ROP) screening efficiency. It is based on gestational age, birth weight and postnatal weight gain. The current study aimed to validate the G-ROP model's ability to predict ROP in cohorts of premature infants from Egypt and the United Kingdom (UK). We retrospectively reviewed the records of preterm infants born between 1st of January and 30th of June 2018 with a known outcome for ROP screening and regular weight measurements until day 39 after birth. We applied the G-ROP model to the study group and calculated the sensitivity of the model for detecting Early Treatment of ROP (ETROP) study type 1 ROP and for any ROP and calculated the reduction of the number of infants requiring ROP screening by the model application. We applied the G-ROP model on 605 infants (504 from Egypt and 101 from the UK). The model successfully predicted all type 1 ROP cases (100% sensitivity) in both cohorts (95% confidence interval [CI], 91.1–100% in the Egyptian cohort and 65.5–100% in the UK cohort). The model reduced the number of infants requiring screening by 14.1% in the Egyptian cohort and 21.8% in the UK cohort. The G-ROP model was successfully validated for detecting type 1 ROP and in both cohorts from Egypt and the UK. [ABSTRACT FROM AUTHOR]

To describe the clinical presentation, risk factors, and treatment choices documented in a pediatric keratoconus population treated at a tertiary referral center in Alexandria, Egypt. : A cross-sectional study of 80 patients with keratoconus aged 18 years or younger referred to the cornea clinic at the Alexandria University Main Hospital between July 2018 and October 2019 was included. Patients' history, initial presentation, best spectacle corrected visual acuity (BSCVA), clinical signs, topographic data, and treatment were recorded. Thirty patients were younger than 14 years and 50 were 14 years or older. Elements of the initial presentation included decreased vision in 26 patients, itching in 20 patients, both visual impairment and itching in 16 patients, accidental discovery during vision screening at school in 15 patients, and hydrops in three patients. All patients had bilateral keratoconus, except for four patients who had previously been treated by keratoplasty (n = 156 eyes). The mean logMAR BSCVA was 0.79 ± 0.63. The mean of the average keratometry (AveK), maximum keratometry (Kmax), central corneal thickness (CCT) and thinnest pachymetry reading were 51.16 ± 7.31 D, 59.18 ± 10.38 D, 458.44 ± 55.87 µ 440.08 ± 60.18 µ, respectively. 57 eyes (36%) had stage 1 disease, 43 eyes (28%) had stage 2 disease, 17 eyes (11%) had stage 3 disease and 39 eyes (25%) had stage 4 disease, respectively. No statistically significant differences in the LogMAR BSCVA, keratometry values, CCT, thinnest pachymetry reading, and the Amsler-Krumeich (AK) staging existed between the two age groups or between boys and girls. Crosslinking was indicated in 69 eyes (44%), while keratoplasty was the only viable solution for 39 eyes (25%), with three patients requiring keratoplasty in both eyes. Keratoconus in children can result in severe loss of vision. Keratoconus screening programs in elementary schools should be considered in populations with a high incidence of keratoconus for early detection and adequate intervention. [ABSTRACT FROM AUTHOR]